Normalization of Function in Pediatric Dilated Cardiomyopathy

Because their analysis was limited to a 2-year time frame, the authors did not report how many of the surviving normalized patients developed late secondary deterioration in LVEDD and function. [...]new antifibrosis and myocellular therapeutic strategies are needed to increase the proportion of pati...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2014-04, Vol.63 (14), p.1414-1415
Main Author: Lewis, Alan B., MD
Format: Article
Language:English
Subjects:
Age
Biopsy
Cardiology
Cardiomyopathy
Cardiovascular
Heart attacks
Heart failure
Internal Medicine
Medical prognosis
Multivariate analysis
Pediatrics
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2197-10d1fb9b5e7c953b8dd2df7fe8c878a563a8e1e9c6f18ab916f4d33400d1fa313
cites cdi_FETCH-LOGICAL-c2197-10d1fb9b5e7c953b8dd2df7fe8c878a563a8e1e9c6f18ab916f4d33400d1fa313
container_end_page 1415
container_issue 14
container_start_page 1414
container_title Journal of the American College of Cardiology
container_volume 63
creator Lewis, Alan B., MD
description Because their analysis was limited to a 2-year time frame, the authors did not report how many of the surviving normalized patients developed late secondary deterioration in LVEDD and function. [...]new antifibrosis and myocellular therapeutic strategies are needed to increase the proportion of patients with pediatric DCM who undergo reverse remodeling and long-term recovery of LV size and function.
doi_str_mv 10.1016/j.jacc.2014.01.037
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1513506179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109714004550</els_id><sourcerecordid>3268817141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2197-10d1fb9b5e7c953b8dd2df7fe8c878a563a8e1e9c6f18ab916f4d33400d1fa313</originalsourceid><addsrcrecordid>eNpFkMtKxDAUhoMoOI6-gKuC69acpmmShYKMVxhUUNchkwumdpox6Qj16W0dwdU5i__Gh9Ap4AIw1OdN0SitixJDVWAoMGF7aAaU8pxQwfbRDDNCc8CCHaKjlBqMcc1BzNDFY4hr1fpv1fvQZcFlt9tO__6-y56t8aqPXmfXvlW9NdlCRePDeggb1b8Px-jAqTbZk787R2-3N6-L-3z5dPewuFrmugTBxl4DbiVW1DItKFlxY0rjmLNcc8YVrYniFqzQtQOuVgJqVxlCKjz5FAEyR2e73E0Mn1ubetmEbezGSgkUCMU1MDGqyp1Kx5BStE5uol-rOEjAcsIkGzlhkhMmiUGOmEbT5c5kx_1f3kapW995rdoPO9j03yNTKbF8mUBOHGFcV1GKyQ8PsnDG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1513506179</pqid></control><display><type>article</type><title>Normalization of Function in Pediatric Dilated Cardiomyopathy</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Lewis, Alan B., MD</creator><creatorcontrib>Lewis, Alan B., MD</creatorcontrib><description>Because their analysis was limited to a 2-year time frame, the authors did not report how many of the surviving normalized patients developed late secondary deterioration in LVEDD and function. [...]new antifibrosis and myocellular therapeutic strategies are needed to increase the proportion of patients with pediatric DCM who undergo reverse remodeling and long-term recovery of LV size and function.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2014.01.037</identifier><language>eng</language><publisher>New York: Elsevier Limited</publisher><subject>Age ; Biopsy ; Cardiology ; Cardiomyopathy ; Cardiovascular ; Heart attacks ; Heart failure ; Internal Medicine ; Medical prognosis ; Multivariate analysis ; Pediatrics ; Studies</subject><ispartof>Journal of the American College of Cardiology, 2014-04, Vol.63 (14), p.1414-1415</ispartof><rights>American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Apr 15, 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2197-10d1fb9b5e7c953b8dd2df7fe8c878a563a8e1e9c6f18ab916f4d33400d1fa313</citedby><cites>FETCH-LOGICAL-c2197-10d1fb9b5e7c953b8dd2df7fe8c878a563a8e1e9c6f18ab916f4d33400d1fa313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Lewis, Alan B., MD</creatorcontrib><title>Normalization of Function in Pediatric Dilated Cardiomyopathy</title><title>Journal of the American College of Cardiology</title><description>Because their analysis was limited to a 2-year time frame, the authors did not report how many of the surviving normalized patients developed late secondary deterioration in LVEDD and function. [...]new antifibrosis and myocellular therapeutic strategies are needed to increase the proportion of patients with pediatric DCM who undergo reverse remodeling and long-term recovery of LV size and function.</description><subject>Age</subject><subject>Biopsy</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Cardiovascular</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Internal Medicine</subject><subject>Medical prognosis</subject><subject>Multivariate analysis</subject><subject>Pediatrics</subject><subject>Studies</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpFkMtKxDAUhoMoOI6-gKuC69acpmmShYKMVxhUUNchkwumdpox6Qj16W0dwdU5i__Gh9Ap4AIw1OdN0SitixJDVWAoMGF7aAaU8pxQwfbRDDNCc8CCHaKjlBqMcc1BzNDFY4hr1fpv1fvQZcFlt9tO__6-y56t8aqPXmfXvlW9NdlCRePDeggb1b8Px-jAqTbZk787R2-3N6-L-3z5dPewuFrmugTBxl4DbiVW1DItKFlxY0rjmLNcc8YVrYniFqzQtQOuVgJqVxlCKjz5FAEyR2e73E0Mn1ubetmEbezGSgkUCMU1MDGqyp1Kx5BStE5uol-rOEjAcsIkGzlhkhMmiUGOmEbT5c5kx_1f3kapW995rdoPO9j03yNTKbF8mUBOHGFcV1GKyQ8PsnDG</recordid><startdate>20140415</startdate><enddate>20140415</enddate><creator>Lewis, Alan B., MD</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20140415</creationdate><title>Normalization of Function in Pediatric Dilated Cardiomyopathy</title><author>Lewis, Alan B., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2197-10d1fb9b5e7c953b8dd2df7fe8c878a563a8e1e9c6f18ab916f4d33400d1fa313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Age</topic><topic>Biopsy</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Cardiovascular</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Internal Medicine</topic><topic>Medical prognosis</topic><topic>Multivariate analysis</topic><topic>Pediatrics</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lewis, Alan B., MD</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lewis, Alan B., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Normalization of Function in Pediatric Dilated Cardiomyopathy</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2014-04-15</date><risdate>2014</risdate><volume>63</volume><issue>14</issue><spage>1414</spage><epage>1415</epage><pages>1414-1415</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Because their analysis was limited to a 2-year time frame, the authors did not report how many of the surviving normalized patients developed late secondary deterioration in LVEDD and function. [...]new antifibrosis and myocellular therapeutic strategies are needed to increase the proportion of patients with pediatric DCM who undergo reverse remodeling and long-term recovery of LV size and function.</abstract><cop>New York</cop><pub>Elsevier Limited</pub><doi>10.1016/j.jacc.2014.01.037</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2014-04, Vol.63 (14), p.1414-1415
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1513506179
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Age
Biopsy
Cardiology
Cardiomyopathy
Cardiovascular
Heart attacks
Heart failure
Internal Medicine
Medical prognosis
Multivariate analysis
Pediatrics
Studies
title Normalization of Function in Pediatric Dilated Cardiomyopathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A06%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Normalization%20of%20Function%20in%20Pediatric%20Dilated%20Cardiomyopathy&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Lewis,%20Alan%20B.,%20MD&rft.date=2014-04-15&rft.volume=63&rft.issue=14&rft.spage=1414&rft.epage=1415&rft.pages=1414-1415&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2014.01.037&rft_dat=%3Cproquest_cross%3E3268817141%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2197-10d1fb9b5e7c953b8dd2df7fe8c878a563a8e1e9c6f18ab916f4d33400d1fa313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1513506179&rft_id=info:pmid/&rfr_iscdi=true